Locoregional recurrence in rectal cancer;Recidiva locorregional en el cáncer de recto

Cirugia Espanola

Volumn 73, Issue 1, 2003, Pages 63-67

  Cerdán Miguel, Javier ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Locoregional recurrence; Rectal cancer

Indexed keywords

EID: 84897764935     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(03)72093-4     Document Type: Article

References (36)

1. Wheeler J.M.D., Warren B.F., Mortensen N.J.Mc.C, Ekanyaka N., Kulacoglu H., Jones A.C., et al. Quantification of histologic regression of rectal cancer after irradiation. Dis Colon Rectum 2002, 45:1051-1056.
2. Yamada K., Ishizawa T., Niwa K., Chuman Y., Aikon T. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 2002, 45:1078-1084.
3. Radice E., Dozois R.R. Locally recurrent rectal cancer. Dig Surg 2001, 18:355-362.
4. Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg 1982, 69:613-616.
5. Chapuis P., Bokey L., Fahrer M., Sinclair G., Comm M., Bogduk N. Mobilization of the rectum. Anatomic concepts and the bookshelf revisited. Dis Colon Rectum 2002, 45:1-9.
6. Ratto C., Ricci R., Rossi C., Morelli U., Vecchio F.M., Doglietto G.B. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 2002, 45:733-743.
7. Ono C.h., Yoshinaga K., Enomoto M., Sugihare K. Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margen in situ. Dis Colon Rectum 2002, 45:744-749.
8. Read T.E., Myerson R.J., Fleshman J.W., Fry R.D., Birnbaum E.H., Walz B.J., et al. Surgeon specialty is associated with outcome in rectal cancer treatment. Dis Colon Rectum 2002, 45:904-914.
9. Wibe A., Moller B., Norstein J., Carlsen E., Wiig J.N., Heald R.J., et al. A national strategic change in treatment policy for rectal cancer implementation of total mesorectal escisión as routine treatment in Norway. A national audit. Dis Colon Rectum 2002, 45:857-866.
10. Romero M., Alós R., Aparicio J., Estevan R., García J., Grau E., et al. Resumen de la guía práctica clínica en el cáncer colorrectal de la Sociedad Valenciana de Cirugía. Cir Esp 1999, 65:326-330.
11. Heald R.J., Moran B.J., Ryall R.D., Sexton R., Mac Farlane J.K. Rectal cancer: basingstoke experience of total mesorectal excision 1978- 1992. Arch Surg 1998, 133:894-899.
12. Holm T., Johansson H., Cedermark B., Ekelund G., Rutqvist L.E. Influence of hospital-and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 1997, 84:657-663.
13. López-Kostner F., Fazio V.W., Vignali A., Rybicki L.A., Lavery I.C. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001, 44:173-178.
14. Cerdán J., Cantero R., López J.A., Talavera P., Cascón A., Balibrea J.L. Cáncer de recto: exfoliación celular durante la disección rectal y valor del lavado peroperatorio. Cir Esp 1998, 64:581-583.
15. Quirke P., Dixon M.T., Durdey P., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986, 1:996-998.
16. Porter G.A., Soskoline C.L., Yakimets W.W., Newman S.C. Surgeon-related factors and outcomes in rectal cancer. Ann Surg 1998, 227:157-167.
17. Cerdán J. Seguimiento de los pacientes intervenidos de cáncer colorrectal. Rev Cáncer 1997, 11:32-41.
18. Komborozos V.A., Skrekas G.J., Pissiotis C.A. The contribution of follow- up programs in the reduction of mortality of rectal cancer recurrences. Dig Surg 2001, 18:403-408.
19. Méndez R.J., Rodríguez R., Kovacevich T., Martínez S., Moreno G., Cerdán F.J. CT in the detection of local recurrence of rectal carcinoma. J Comput Assist Tomogr 1993, 17:741-744.
20. Robinson P., Carrington B.M., Swindell R., Shanks J.H., O'Dwyer S.T. Recurrent or residual pelvic bowed cancer: accuracy of MRI local extent before salvage surgery. Clin Radiol 2002, 57:514-522.
21. Lucha P.A.Jr., Rosen L., Olenwine J.A., Reed J.F., Riether R.D., Stasik J.J., et al. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorrectal carcinoma. Dis Colon Rectum 1997, 40:145-149.
22. Baulieu F., Bourlier P., Scotto B., Mor C., Eder V., Picon L., et al. The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Nucl Med Commun 2001, 22:1295-1304.
23. García-Aguilar J., Cromwell J.W., Marra C., Lee S.H., Madoff R.D., Rothenberger D.A. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001, 44:1743-1748.
24. Mannaerts G.H., Rutten H.J., Martijn H., Groen G.J., Hanssens P.E., Wiggers T. Abdominosacral resection for primary irresectable and locally recurrent rectal cancer. Dis Colon Rectum 2001, 44:806-814.
25. Wanebo H.J., Antoniuk P., Koness R.J., Levy A., Vezeridis M., Cohen S.I., et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcome. Dis Colon Rectum 1999, 42:1438-1448.
26. Shoup M., Guillem J.G., Alektiar K.M., Lian K., Paty P.B., Cohen A.M., et al. Predictor of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002, 45:585-592.
27. Wiig J.N., Tveit K.M., Poulsen J.P., Olsen D.R., Giercksky K.E. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002, 62:207-213.
28. Williams L.F., Huddleston C.B., Sawyers J.L., Potts J.R., Sharp K.W., McDougal S.W. Is total pelvic exenteration reasonable primary treatment for rectal carcinoma. Ann Surg 1988, 207:670-678.
29. Wiig J.N., Poulsen J.P., Larsen S., Braendengen M., Waehre H., Giercksky K.E. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002, 168:42-48.
30. Ketcham H.S. The management of recurrent rectal cancer. Can J Surg 1985, 28:422-424.
31. Yamada K., Ishizawa T., Niwa K., Chuman Y., Akiba S., Aikon T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001, 88:988-993.
32. Mohiuddin M., Marks G., Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002, 95:1144-1150.
33. Pacini P., Cionini L., Pirtoli L., Ciatto S., Tucci E., Sebaste L. Syntomatic recurrences of carcinoma of the rectum and sigmoid. The influence of radiotherapy on the quality of life. Dis Colon Rectum 1986, 29:865-868.
34. Mannaerts G.H., Rutten H.J., Martijn H., Hanssens P.E., Wiggers T. Effects on functional outcome after IORT-containing multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2002, 54:1082-1088.
35. Yárnoz C., Sanz A., Cuesta L., Montes M., De Miguel M., Ortiz H. ¿Disminuye la radioterapia la frecuencia de implantes en el mesorrecto?. Cir Esp 1999, 65:374-376.
36. Esnaola N.T., Cantor S.B., Johnson M.L., Mirza A.N., Miller A.R., Curley S.A., et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002, 20:4361-4367.